GLP-3R is positioned as a tri-receptor endocrine signaling research tool intended to support controlled bench studies that map receptor proximal activity, pathway kinetics, and downstream marker ...

Association of circulating T lymphocytes and their functional states with pathologic complete response (pCR) in breast cancer (BC). A prospective Italian study. This is an ASCO Meeting Abstract from ...

The exceptional immune tolerance of the liver is, in part, mediated by entero-pancreatic endocrine factors that enter the portal vein at elevated levels. These endocrine factors signal via cAMP, ...

Collaborative research led by ARG's Medical Affairs Team and Scientific Advisory Board reinforces the company's commitment to thyroid category leadership The research presents an integrative framework ...

In some cases, HR-positive/HER2-negative breast cancers may over time become resistant to endocrine therapy. This can occur through mutations in the estrogen receptor ...

CDK 4/6 inhibitors (CDK4/6i) remain part of the standard first-line treatment for patients with hormone receptor–positive metastatic breast cancer, offering demonstrable improvements in both ...

WASHINGTON—The Endocrine Society today announced it has chosen 14 leading endocrinologists as winners of its prestigious 2025 Laureate Awards, the top honors in the field. Endocrinologists are ...